Ascites - 120 Studies Found
| Completed |
: Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites : Refractory Malignant Ascites : 2013-05-08 : Drug: bevacizumab Other Name: Avastin |
| Completed |
: A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal : Refractory Ascites : 2009-03-25 : Device: AFS System AFS System with patient specific flow rate |
| Terminated |
: Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites : Malignant Ascites : 2015-07-01 : Drug: Intraperitoneal Bevacizumab Bevacizumab 200mg diluted in 250 ml of normal saline |
| Completed |
: Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia : Cirrhotic Ascites : 2010-08-10 :
|
| Completed |
: Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial. : Massive Ascites : 2016-08-11 :
|
| Completed |
: Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites : Refractory Malignant Ascites : 2016-09-01 : Other: No intervention. Descriptive study |
| Completed |
: Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites :
: 2007-07-13 : Drug: satavaptan (SR121463B) |
| Completed |
: Satavaptan Dose-Ranging Study in the Prevention of Ascites :
: 2007-07-13 : Drug: satavaptan (SR121463B) |
| Completed |
: ALFApump System Versus Standard of Care in Ascites Treatment : Refractory or Recurrent Ascites : 2012-01-31 :
|
| Completed |
: Safety Study of Second Intraperitoneal (I.P.) Infusion Cycle of Catumaxomab in Patients With Malignant Ascites : Malignant Ascites Due to Epithelial Carcinoma : 2010-01-13 : Drug: catumaxomab 4 intraperitoneal infusions within 11 days administered over 3 hours via an indwelling |